Update date: Jan. 21, 2020
Shizuoka Cancer Center, Research Institute
静岡県立静岡がんセンター 研究所, シズオカケンリツシズオカガンセンター ケンキュウジョ
Director of Research Institute Ken YAMAGUCHI
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture 411-8777, Japan
Organization/Research department name (1)：
Subordinate facility name (1)：
Medical Genetics Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Immunotherapy Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Proton Therapy Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Cancer Survivorship Research Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Nursing Care Research Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Cancer Diagnostics Research Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Region Resources Division\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Drug Discovery and Development Division
Central Laboratory\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Experimental Animal Facility\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t Information Management Office
Purpose of establishment：
Shizuoka Cancer Center was established.
Research Institute was completed.
In the fall of 2005, a new building of the Research Institute
was established adjacent to the Hospital to achieve the Research
Institute’s three missions: the development of new medical
technology for cancer treatment, the development of new tools
to support patients and their families, and the promotion of
the Mt. Fuji Pharma Valley Initiatives. The Pharma Valley Center,
which is affiliated with the Shizuoka Organization for Creation
of Industries, also sets up in the Research Institute to play an
important role for the initiatives.
Management of the Shizuoka Cancer Center Research Institute
Return to Previous Page
emphasizes the following three policies are emphasized.
The first policy is to collaborate with the Hospital and
the Disease Management Center to practice “Research to pursue
patient-first medical care”. In order to do this, the institute
carries out research aimed at cancer cures, as well as research
on tools and skills that ease the pain and anxiety of patients
and families. The focal points for patient care are the Cancer
Survivorship Research Division and the Nursing Care Research Division.
These divisions are unique features which are not found
in any other cancer research institute in Japan.
The second policy is to carry out “Project-oriented research.”
Exhaustive discussions are conducted before selecting a research
theme that medical staffs and patients find useful.
The research is implemented with the collaboration of the Center
staff and researchers from affiliated universities and industries.
The outcomes of the research thus obtained are examined and verified
at the Hospital. To promote collaborative research of medicine,
nursing and engineering, the joint laboratories have been set up
in the Research Institute for use by industry, academia and government.
The third policy is “Equal partnership” between researchers belonging to
industry, academia or government. To make this possible, visiting
researchers are encouraged to learn a lot about clinical practice
in the Hospital.
Newly-developed technologies and tools useful for medicine and
nursing will spread to medical institutions in Shizuoka Prefecture
as well as the rest of Japan and the world, and will contribute
to improved medical care for patients. It is also expected that,
with advancements in the Mt. Fuji Pharma Valley Initiatives,
‘bed-side’ clusters for fostering experts, manufacturing
innovative products and building comfortable and prosperous
towns will become a reality, and that health and medical industries
in Shizuoka will be further invigorated.